Target intelligence / Profile preview

Pre-messenger RNA non-productive exon sequences (Poison exons)

Target
Poison exons
Molecular classification
RNA, Pre-messenger RNA, Regulatory element, Cis-acting element
01

Overview

Pre-messenger RNA non-productive exon sequences, commonly referred to as "poison exons," are highly conserved segments within pre-messenger RNA that, when included in the mature transcript, introduce a premature termination codon (PTC). This inclusion triggers the nonsense-mediated decay (NMD) pathway, a cellular quality control mechanism that degrades the mRNA to prevent the translation of truncated or potentially toxic proteins (Lim et al., 2020, Nature Communications). These sequences function as natural regulatory elements that cells use to downregulate gene expression post-transcriptionally. In therapeutic contexts, these sequences are targeted to treat diseases caused by haploinsufficiency, where a single functional copy of a gene is insufficient for normal health. Antisense oligonucleotides (ASOs) are designed to bind to these non-productive sequences or their flanking splice sites, preventing their inclusion in the final mRNA (Stoke Therapeutics, 2024). By "skipping" the poison exon, the splicing machinery produces a productive, full-length mRNA transcript, thereby increasing the total amount of functional protein. This approach, known as Targeted Augmentation of Nuclear Gene Output (TANGO), is currently being evaluated in clinical trials for conditions such as Dravet syndrome and Autosomal Dominant Optic Atrophy (Lim et al., 2020).

Other names
Poison exonsCryptic exonsPseudoexonsNon-productive alternative exonsAS-NMD exonsStop-codon-containing exons
02

Mechanism of action

Antisense oligonucleotides bind to specific sequences within or near the non-productive exon to modulate splicing, typically promoting exon skipping to prevent the inclusion of premature termination codons and thereby avoiding nonsense-mediated decay to increase functional protein expression (Lim et al., 2020; Stoke Therapeutics, 2024).

03

Biological functions

Alternative splicingNonsense-mediated decay (NMD)Post-transcriptional regulation of gene expression
04

Disease associations

Dravet syndromeAutosomal dominant optic atrophyHaploinsufficiency-related genetic disordersCancerNeurodegenerative disease
05

Safety considerations

Off-target hybridization to unintended RNA sequencesPotential for over-expression of the target protein beyond physiological levelsInflammatory or immune responses to the oligonucleotide backboneDelivery challenges to specific tissues like the central nervous system
06

Interacting drugs

STK-001

2 more in the full profile.

07

Biomarkers

Ratio of productive to non-productive mRNA isoformsTotal functional protein levelsClinical efficacy measures (e.g., seizure frequency in Dravet syndrome)

Beyond the preview

Go deeper on Pre-messenger RNA non-productive exon sequences (Poison exons).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pre-messenger RNA non-productive exon sequences (Poison exons).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call